Takeda Strikes Microbiome Deal with Canada’s NuBiyota

April 12, 2017
Takeda Pharmaceutical said on April 11 that it has concluded a strategic collaboration with Canada’s NuBiyota for the development of microbiome therapeutics in yet another deal to beef up its GI franchise. Under the deal, the two sides will work...read more